Virus-resistant wheat could aid UK farmers denied access to neonicotinoid insecticides

screenshot mild autumn increases virus threat to cereal crops farmers weekly
Barley yellow dwarf virus in wheat. Credit: Farmers Weekly

RAGT Seeds is to launch a winter wheat variety with a high level of resistance to barley yellow dwarf virus (BYDV) to the UK market next autumn, offering farmers an alternative to chemical control for the first time.

The introduction of RGT Wolverine marks a major breakthrough in European variety development and is particularly timely following the withdrawal in 2018 of neonicotinoid seed treatments for wheat, which has left growers relying on less effective insecticide sprays to control aphid vectors, according to RAGT.

Crucially, the variety is capable of delivering exceptional yields even in the absence of BYDV and is backed by a strong agronomic package, so growers will not be penalized for choosing it in low-disease years, says RAGT’s cereal and OSR product manager Tom Dummett.

“RAGT is the first breeder in Europe to offer a BYDV-resistant wheat, and the trait is now successfully established in some of our elite material.”

RGT Wolverine’s resistance originates from a goat grass, Thinopyrum intermedium, a distant wheat relative. A genetic segment from Thinopyrum containing the resistance gene Bdv2 has been translocated onto a wheat chromosome via an Australian research line known as TC14.

Read full, original article: RAGT to launch BYDV-resistant wheat

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-06-17-at-12.31.01-PM
Viewpoint: The dangerous influence of ‘woke’ post-modernism in science
Screenshot-2026-06-26-at-10.14.50-AM
Viewpoint: The facts behind the grifter-promoting wellness and anti-aging peptide craze: Don’t waste your money
ChatGPT-Image-Jun-26-2026-01_21_33-PM
How the dubious, Trump-backed, addictive drug kratom could enrich cabinet secretary Markwayne Mullin
Screenshot-2026-06-25-at-11.18.03-AM
Viewpoint: Appreciating a simpler past without swallowing the misleading ‘nature is healthier and safer’ myth
ChatGPT-Image-Jun-26-2026-12_10_16-PM
Europe’s heat wave fueled recycled climate-denial narratives and harassment of climate scientists
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-06-25-at-1.48.40-PM
Glyphosate affirmed as safe: Supreme Court rejects lawsuit claiming Roundup herbicide causes cancer, upholding EPA determination
ChatGPT-Image-Jun-26-2026-11_34_33-AM
Viewpoint: RFK, Jr.’s vaccine subterfuge campaign now flies below the media radar
ChatGPT-Image-Jun-19-2026-04_11_20-PM
Daubert for Dummies—Scientific Reliability in U.S. Courts: Daubert, Rule 702, and Made-for-Litigation Evidence
ChatGPT-Image-Jun-17-2026-10_52_43-AM
Anguished parents, doctors in tears: Utah’s long measles outbreak takes a toll
ChatGPT-Image-Jun-23-2026-01_12_57-PM
After Mel Gibson’s Joe Rogan comments, grifters promoting ivermectin, without evidence, as a hantavirus preventive 
ChatGPT-Image-Jun-23-2026-03_12_23-PM
Is cellular reprogramming junk science? Nearly 20 patients are getting eye injections in the first FDA-cleared cellular trial
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.